Profile data is unavailable for this security.
About the company
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
- Revenue in EUR (TTM)2.07bn
- Net income in EUR203.20m
- Incorporated1995
- Employees4.95k
- LocationCarl Zeiss Meditec AGGoeschwitzer Strasse 51-52JENA 07745GermanyDEU
- Phone+49 3 641220331
- Fax+49 3 641220117
- Websitehttps://www.zeiss.de/meditec-ag/
Mergers & acquisitions
Acquired company | AFXX:GER since announced | Transaction value |
---|---|---|
DORC Dutch Ophthalmic Research Center (International) BV | -39.95% | 1.08bn |
Holder | Shares | % Held |
---|---|---|
Invesco Advisers, Inc.as of 05 Sep 2024 | 2.13m | 2.38% |
Comgest SAas of 31 May 2024 | 1.97m | 2.21% |
DWS Investment GmbHas of 31 Jul 2024 | 1.42m | 1.59% |
Norges Bank Investment Managementas of 31 Dec 2023 | 1.40m | 1.57% |
The Vanguard Group, Inc.as of 04 Sep 2024 | 1.29m | 1.45% |
Allianz Global Investors GmbHas of 31 Jul 2024 | 1.14m | 1.28% |
Candriam Belgium SAas of 31 Aug 2024 | 876.34k | 0.98% |
BlackRock Fund Advisorsas of 05 Sep 2024 | 698.00k | 0.78% |
BlackRock Asset Management Deutschland AGas of 06 Sep 2024 | 577.32k | 0.65% |
Rathbones Asset Management Ltd.as of 31 Jul 2024 | 446.38k | 0.50% |